Literature DB >> 16709942

Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more).

Kevin D O'Brien1.   

Abstract

BACKGROUND: Over the past 10 to 15 years, calcific aortic valve disease, which includes aortic sclerosis and aortic stenosis, has come to be recognized as an active process, based on: (1) epidemiologic studies demonstrating associations of specific risk factors with increased prevalence or rate of progression of aortic valve disease; (2) identification, in valve lesions, of histopathologic features of chronic inflammation, lipoprotein deposition, renin-angiotensin system components, and molecular mediators of calcification; and (3) identification of cell-signaling pathways and genetic factors that may participate in valve disease pathogenesis. These studies will be reviewed and organized into a proposed global hypothesis for the pathogenesis of calcific aortic valve disease.

Entities:  

Mesh:

Year:  2006        PMID: 16709942     DOI: 10.1161/01.ATV.0000227513.13697.ac

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  86 in total

1.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

2.  Valvular disease: The private life of tissue valves.

Authors:  Magdi H Yacoub; Ismail El-Hamamsy
Journal:  Nat Rev Cardiol       Date:  2010-08       Impact factor: 32.419

Review 3.  The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.

Authors:  Sammy Elmariah; Emile R Mohler
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

4.  Differential proteoglycan and hyaluronan distribution in calcified aortic valves.

Authors:  Elizabeth H Stephens; Jerome G Saltarrelli; L Scott Baggett; Indrajit Nandi; Joyce J Kuo; Alan R Davis; Elizabeth A Olmsted-Davis; Michael J Reardon; Joel D Morrisett; Kathryn Jane Grande-Allen
Journal:  Cardiovasc Pathol       Date:  2010-12-24       Impact factor: 2.185

5.  Differences in valvular and vascular cell responses to strain in osteogenic media.

Authors:  Zannatul Ferdous; Hanjoong Jo; Robert M Nerem
Journal:  Biomaterials       Date:  2011-02-01       Impact factor: 12.479

Review 6.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology.

Authors:  Amber C Liu; Vineet R Joag; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

7.  Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix.

Authors:  Edward B Neufeld; Leah M Zadrozny; Darci Phillips; Angel Aponte; Zu-Xi Yu; Robert S Balaban
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

8.  Reduced sox9 function promotes heart valve calcification phenotypes in vivo.

Authors:  Jacqueline D Peacock; Agata K Levay; Devin B Gillaspie; Ge Tao; Joy Lincoln
Journal:  Circ Res       Date:  2010-01-07       Impact factor: 17.367

9.  Wnt signaling in heart valve development and osteogenic gene induction.

Authors:  Christina M Alfieri; Jonathan Cheek; Santanu Chakraborty; Katherine E Yutzey
Journal:  Dev Biol       Date:  2009-12-01       Impact factor: 3.582

10.  Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice.

Authors:  Cordelia J Barrick; Reade B Roberts; Mauricio Rojas; Nalini M Rajamannan; Carolyn B Suitt; Kevin D O'Brien; Susan S Smyth; David W Threadgill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.